Startup developing screening tool for polycystic ovary syndrome
It is estimated that 1 in 10 women of childbearing age are living with polycystic ovary syndrome (PCOS), a painful condition for which there is no cure.

Symptoms include irregular or no periods, difficulty getting pregnant, hirsutism, weight gain, hair loss from the head, and acne but it can take years before a positive diagnosis for PCOS is given.
Now, chemical biologist Dr Melis Eda Ekinci aims to rectify this with Woost, a startup developing a home blood test kit for women that will enable them to regularly track biomarkers in their menstrual blood to screen for gynaecological conditions earlier.
“The idea, the inspiration, was to build a test that women can buy easily, online or at the pharmacy, or anywhere where they can - kind of like a pregnancy test – to perform a blood test at home and get results,” she said.
MORE FROM MEDICAL & HEALTHCARE
The kit works in conjunction with a digital platform, where women can analyse their results, understand their symptoms, and access reviewed health information and treatment support.
Although in its early stages, Dr Ekinci expects the solution to deliver results in under half an hour when it reaches the market. Woost is also building an AI-assisted system targeting symptom tracking associated with PCOS, alongside menstrual blood testing.
Register now to continue reading
Thanks for visiting The Engineer. You’ve now reached your monthly limit of news stories. Register for free to unlock unlimited access to all of our news coverage, as well as premium content including opinion, in-depth features and special reports.
Benefits of registering
-
In-depth insights and coverage of key emerging trends
-
Unrestricted access to special reports throughout the year
-
Daily technology news delivered straight to your inbox
Experts speculate over cause of Iberian power outages
I´m sure politicians will be thumping tables and demanding answers - while Professor Bell, as reported above, says ´wait for detailed professional...